Composition
- Active ingredients
- OMEGA-3-CARBOXYLIC ACIDS 1GM CONTAINS AT LEAST 850MG OF POLYUNSATURATED FATTY ACIDS
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA205060.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Epanova
- Active substance
- omega-3-carboxylic acids
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Astrazeneca
- Status
- Discontinued
- FDA approval
- 5 May 2014
- Application
- NDA205060-001